for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-T2 Biosystems Announces Worldwide Licensing Agreement Of Covid-19 Assay

March 24 (Reuters) - T2 Biosystems Inc:

* T2 BIOSYSTEMS ANNOUNCES WORLDWIDE LICENSING AGREEMENT OF COVID-19, NOVEL CORONAVIRUS ASSAY FROM HACKENSACK MERIDIAN HEALTH’S CENTER FOR DISCOVERY AND INNOVATION

* T2 BIOSYSTEMS INC - WILL ADAPT CORONAVIRUS TEST TO RUN ON ITS T2DX INSTRUMENT

* T2 BIOSYSTEMS INC - HACKENSACK MERIDIAN HEALTH WILL ALSO ADOPT T2DX INSTRUMENT AND TEST PANELS Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up